WealthCollab »

Aprea Therapeutics shares owned by WealthCollab

Quarter-by-quarter ownership of Aprea Therapeutics (APRE) shares owned by WealthCollab from 13F filings

Historical chart of WealthCollab investment in Aprea Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aprea Therapeutics held by WealthCollab consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aprea Therapeutics by WealthCollab

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.1k 158 6.70
2023-12-31 $742 158 4.70

More positions owned by WealthCollab

Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
Vanguard Index Fds Total Stk Mkt (VTI)
American Centy Etf Tr Us Sml Cp Valu (AVUV)
Ishares Tr Core Msci Total (IXUS)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
American Centy Etf Tr Intl Smcp Vlu (AVDV)
Schwab Strategic Tr Us Reit Etf (SCHH)
Vanguard Index Fds Real Estate Etf (VNQ)
Vanguard Mun Bd Fds Tax Exempt Bd (VTEB)
Vanguard Bd Index Fds Intermed Term (BIV)
Ssr Mining (SSRM)
Amazon (AMZN)
Ishares Tr National Mun Etf (MUB)
Schwab Strategic Tr Us Brd Mkt Etf (SCHB)
Microsoft Corporation (MSFT)

View all positions for WealthCollab

Top funds holding Aprea Therapeutics

AIGH Capital Management
Sio Capital Management
Sphera Funds Management
Nantahala Capital Management
DAFNA Capital Management
Vanguard Group
Morgan Stanley
Geode Capital Management
HighTower Advisors
BlackRock
Royal Bank of Canada
Group One Trading
Bank of America Corporation
Tower Research Capital
Pnc Financial Services

View all funds holding Aprea Therapeutics